{"product_id":"cst-3159s","title":"CST,  3159S, IFN-gamma (3F1E3) Mouse Monoclonal Antibody","description":"Monoclonal Antibody for studying IFN-gamma. Validated for Western Blotting,Immunoprecipitation,Peptide ELISA (DELFIA). Available in 2 sizes. Highly specific and rigorously validated in-house, IFN-gamma (3F1E3) Mouse Monoclonal Antibody (CST #3159) is ready to ship.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nWestern Blotting: 1:1000\nImmunoprecipitation: 1:50\nPeptide ELISA (DELFIA): 1:100\n\u003cb\u003eStorage\u003c\/b\u003e\nSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg\/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at -20°C. Do not aliquot the antibody.\n\u003cb\u003eProtocol\u003c\/b\u003e\nAvailable protocols: Western Blotting, Immunoprecipitation\n\u003cb\u003eSpecificity \/ Sensitivity\u003c\/b\u003e\nIFN-gamma (3F1E3) Mouse Monoclonal Antibody detects recombinant human IFN-Î³.\nSpecies Reactivity: Human\n\u003cb\u003eSource \/ Purification\u003c\/b\u003e\nMonoclonal antibody is produced by immunizing animals with Ni-NTA purified recombinant human IFN-Î³ expressed in . Antibodies were prepared from ascites.\n\u003cb\u003eBackground\u003c\/b\u003e\nIFN-Î³ plays key roles in both the innate and adaptive immune response. IFN-Î³ activates the cytotoxic activity of innate immune cells, such as macrophages and NK cells (1,2). IFN-Î³ production by NK cells and antigen presenting cells (APCs) promotes cell-mediated adaptive immunity by inducing IFN-Î³ production by T lymphocytes, increasing class I and class II MHC expression, and enhancing peptide antigen presentation (1). Due to differences in the degree of glycosylation, there are three forms of IFN-Î³, with approximate molecular weights of 25, 20, and 15.5 kDa by SDS-PAGE (5). The anti-viral activity of IFN-Î³ is due to its induction of PKR and other regulatory proteins. Binding of IFN-Î³ to the IFNGR1\/IFNGR2 complex promotes dimerization of the receptor complexes to form the (IFNGR1\/IFNGR2) -IFN-Î³ dimer. Binding induces a conformational change in receptor intracellular domains and signaling involves Jak1, Jak2, and Stat1 (3). The critical role of IFN-Î³ in amplification of immune surveillance and function is supported by increased susceptibility to pathogen infection by IFN-Î³ or IFNGR knockout mice and in humans with inactivating mutations in or . IFN-Î³ also appears to have a role in atherosclerosis (4). IFN-Î³, also known as type II interferon, is produced mainly in activated T lymphocytes and natural killer cells (4) and has broad effects on various cells of the immune system. Many signaling proteins including IL-2, FGF, and EGF induce the synthesis of IFN-Î³.\n\u003cb\u003eAlternate Names\u003c\/b\u003e\nIFG; IFI; IFN-gamma; IFNG; IMD69; Immune interferon; Interferon gamma; interferon, gamma\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H\nSENSITIVITY: Recombinant protein\nMW (kDa): 17\nSource\/Isotype: Mouse IgG1","brand":"CST","offers":[{"title":"Default Title","offer_id":46798074380457,"sku":"3159S","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-3159s","provider":"Iright","version":"1.0","type":"link"}